1. 1317: FEIBA® Reversal for Apixaban and Rivaroxaban in Intracranial and Nonintracranial Hemorrhage. (January 2021) Authors: Hunt, Aleah; Coffeen, Shawn; Shiltz, Dane; Ice, Calvin; Parker, Jessica Journal: Critical care medicine Issue: Volume 49:Supplement 1 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 773: INCIDENCE AND PREDICTIVE FACTORS ASSOCIATED WITH BETA-LACTAM NEUROTOXICITY IN THE CRITICALLY ILL. (16th December 2021) Authors: Haddad, Natalie; Schreier, Diana; Fugate, Jennifer; Gajic, Ognjen; Hocker, Sara; Ice, Calvin; Leung, Sarah; Mara, Kristin; Rabinstein, Alejandro; Rule, Andrew; Barreto, Erin Journal: Critical care medicine Issue: Volume 50(2022)Supplement 1 Page Start: 381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 773: INCIDENCE AND PREDICTIVE FACTORS ASSOCIATED WITH BETA-LACTAM NEUROTOXICITY IN THE CRITICALLY ILL. (January 2022) Authors: Haddad, Natalie; Schreier, Diana; Fugate, Jennifer; Gajic, Ognjen; Hocker, Sara; Ice, Calvin; Leung, Sarah; Mara, Kristin; Rabinstein, Alejandro; Rule, Andrew; Barreto, Erin Journal: Critical care medicine Issue: Volume 50(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 903: Furosemide-Induced Contraction Alkalosis. (January 2021) Authors: Dieso, Patricia; Kiracofe, Brittany; Fay, Lauren; Parker, Jessica; Ice, Calvin Journal: Critical care medicine Issue: Volume 49:Supplement 1 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 905: FEIBA AND ANDEXANET ALFA FOR THE REVERSAL OF APIXABAN AND RIVAROXABAN IN UNCONTROLLED HEMORRHAGE. (16th December 2021) Authors: Ice, Calvin; Gurka, Matthew; Parker, Jessica; Hunt, Aleah Journal: Critical care medicine Issue: Volume 50(2022)Supplement 1 Page Start: 449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 905: FEIBA AND ANDEXANET ALFA FOR THE REVERSAL OF APIXABAN AND RIVAROXABAN IN UNCONTROLLED HEMORRHAGE. (January 2022) Authors: Ice, Calvin; Gurka, Matthew; Parker, Jessica; Hunt, Aleah Journal: Critical care medicine Issue: Volume 50(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Factor VIII Inhibitor Bypassing Activity (FEIBA) Reversal for Apixaban and Rivaroxaban in Patients With Acute Intracranial and Nonintracranial Hemorrhage. Issue 12 (December 2021) Authors: Hunt, Aleah R.; Coffeen, Shawn N.; Shiltz, Dane L.; Ice, Calvin; Parker, Jessi Journal: Annals of pharmacotherapy Issue: Volume 55:Issue 12(2021) Page Start: 1455 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗